Arkolith/Insider Trading/ELYM/Form 4

Kolchinsky Peter

Director, 10% OwnerEliem Therapeutics, Inc. (ELYM) · full profile →Form 4 · filed Jul 1, 2024
Net Buying
Open-Market Buys
$50.0M
Open-Market Sells
$0
Net Open-Market Flow
$50.0M
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 27, 2024Grant(A)2.5M——2.5M
Jun 27, 2024Grant(A)1.8M——1.8M
Jun 27, 2024Grant(A)973K——11.6M
Jun 27, 2024Buy(P)11.9M$3.84$45.9M23.5M
Jun 27, 2024Buy(P)1.1M$3.84$4.1M2.9M

Transaction Codes

A
Grant / award
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-018708) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML